I-FABP as a Predictor of Gastrointestinal Involvement in Pediatric IgA Vasculitis

Recruiting now

Conditions studied: IgA Vasculitis, Gastrointestinal Involvement

In brief

This prospective observational study aims to evaluate plasma intestinal fatty acid-binding protein (I-FABP) levels in children with IgA vasculitis and investigate their association with gastrointestinal involvement. Blood samples will be collected at diagnosis and during follow-up 2-4 weeks later. The study will assess the potential value of plasma I-FABP as a biomarker for gastrointestinal involvement in pediatric IgA vasculitis.

Key facts

Study ID

NCT07664228

Run by

Bursa City Hospital

People needed

100

Starts

2026-05-15

Expected to finish

2027-05-15

Last updated by the study team

2026-06-24

Who can join

Age: 2 and older, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of IgA vasculitis (Henoch-Schönlein purpura) according to EULAR/PRINTO/PRES classification criteria.
• Age between 2 and 18 years.
• Availability for blood sample collection at diagnosis (baseline visit).
• Ability to attend a routine follow-up visit approximately 2-4 weeks after diagnosis.
• Parent or legal guardian able and willing to provide written informed consent.

You may not qualify if…

• Refusal of informed consent by the parent/legal guardian.
• Inability to obtain a baseline blood sample.
• Inability to complete study follow-up procedures.

Where it is running

• Bursa City Hospital — Bursa, Bursa, Turkey (Türkiye) (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.